Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China Medical Technologies Invests $345 Million In HPV Genotyping Chip

This article was originally published in The Gray Sheet

Executive Summary

China Medical Technologies is acquiring a human papillomavirus genotyping assay which it expects will generate up to $26.5 million in sales next year

You may also be interested in...



Far East Financials: Two Large Chinese Device Firms Report Mixed Growth

China Medical's molecular diagnostic system sales were up 10% in the first quarter to $15.9 million, driven by progress with its fluorescent in situ hybridization probe business, the Beijing company reported Aug. 16

Far East Financials: Two Large Chinese Device Firms Report Mixed Growth

China Medical's molecular diagnostic system sales were up 10% in the first quarter to $15.9 million, driven by progress with its fluorescent in situ hybridization probe business, the Beijing company reported Aug. 16

China Medical Reels In FISH Test Revenues; Q3 Sales Up 51%

Not everyone is losing money in the global economic slump. China Medical Technologies, a Beijing in vitro diagnostics company, generated sales of $33 million in the 2008 third quarter (ended Dec. 31), a 51% increase over the prior-year period, according to unaudited results released March 2

Related Content

Latest News
See All
UsernamePublicRestriction

Register

MT026663

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel